Department of Medicine

February 6, 2013

Linking oxygen, iron and red blood cells

The HIF oxygen-sensing pathway and its responses to low oxygen may be targeted for treatments of anemia and disorders of iron balance.

By Leigh MacMillan
January 31, 2013

Vanderbilt, GE unite to study colon tumor development

Vanderbilt University has partnered with GE Global Research in Niskayuna, N.Y., the technology development arm of the General Electric Company, to better define — at the cellular level — how colon tumors form and develop.

By Bill Snyder
January 31, 2013

Do-it-yourself repair in the kidney

The kidney can mediate its own repair through proliferation of resident immune system cells.

By Leigh MacMillan
January 10, 2013

Three new genetic links to colorectal cancer revealed

Vanderbilt-Ingram Cancer Center investigators have identified three new genetic “hotspots” linked to colorectal cancer.

By VUMC News and Communications
January 10, 2013

Study reviews medication adherence interventions

According to a medical literature review published last month in the Annals of Internal Medicine, approximately 50 percent of medications for chronic disease are not taken as prescribed.

By Paul Govern
December 13, 2012

Hood takes role as associate chief medical officer for VMG

Cardiologist Rob Hood, M.D., assistant professor of Medicine and assistant chief medical officer for the clinics at Vanderbilt Health One Hundred Oaks, has been named associate chief medical officer for Vanderbilt Medical Group.

By Paul Govern
December 7, 2012

Vanderbilt study finds diverse genetic alterations in triple-negative breast cancers

Most triple-negative breast cancer patients who were treated with chemotherapy to shrink the tumor prior to surgery still had multiple genetic mutations in their tumor cells, according to a study by Vanderbilt-Ingram Cancer Center (VICC) investigators.
By VUMC News and Communications
November 29, 2012

Awards honor diabetes research contributions

The recent “Diabetes Day” symposium recognized two Vanderbilt trainees for their potential as future leaders in diabetes research and one longtime staff member for his service to the diabetes research community.
By Leigh MacMillan
November 29, 2012

Record number elected AAAS fellows

Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
By Bill Snyder
November 15, 2012

Heart Association honors Roden’s research efforts

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine and William Stokes Professor of Experimental Therapeutics, received a 2012 Distinguished Scientist Award at the annual Scientific Sessions of the American Heart Association (AHA) last week in Los Angeles.
By Kathy Whitney
November 15, 2012

Grant to bolster care of ventilated ICU patients

Vanderbilt University Medical Center investigators have received a $2.8 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to continue studying ways to improve sedation management for intensive care unit patients who are on mechanical ventilators.
By Jill Clendening
November 8, 2012

Commonly prescribed oral diabetes drug offers cardiac benefits

Patients prescribed the diabetes drug metformin have a lower risk for heart attack, stroke and death than patients taking sulfonylurea drugs.
By VUMC News and Communications
November 1, 2012

Genomic research gains ad-“vantage” with new resources

Vanderbilt University Medical Center has stepped up its support of research aimed at cracking the mysteries of the genome, the master DNA code.
By Bill Snyder
1 … 110 111 112 113 114 … 125